
.jpg)
.png)

Bringing Precision Oncology to the Point of Care
GeneSilico’s multi-modal AI platform empowers oncologists with real time, evidence-based insights across every stage of cancer care.
From diagnosis to treatment planning, our Deep Precision Oncology systemdelivers the confidence, clarity, and precision needed to personalize care and improve outcomes right at the point of care.


For Oncologists
gSage Research Agent: Evidence Based Oncology Intelligence at Your Fingertips
Trusted By Oncologists And
Cancer Researchers Worldwide
- Evidence Based AI-Powered Answers to treatment match, toxcitiy, clinical trails match queries
- FDA Approved Therapy and Dosage Calculations and Treatment Guidelines with Summaries
- Traceability to a response with High Quality and Vetted References
- Earn CME Credits for your searches – Need to validate and figure out how to create this partnership
- Stay up-to-date effortlessly on latest Cancer Therapy Pipeline of FRA Approved Drug and Experimental Drugs
- Search and Review Clinical Trials and Find Matches
For Health Systems
First-of-Its-Kind NGS Panels Built for Precision Cancer Care
GeneSilico’s cancer-specific next-generation sequencing (NGS) panels give oncologists unmatched visibility into tumor biology. Our breast cancer panel analyzes 68 key genes to reveal actionable mutations and pinpoint the most effective treatment options.
Get Started
GeneSilico Ordering Portal: Seamless Access to Precision NGS Testing



The First AI Clinical Assistant Built for Oncology Precision at the Point of Care
GeneSilico’s gSage AI Assistant helps oncologists match the right treatment to the right patient at the right time. Continuously updated with the latest therapy insights, it guides clinicians through personalized plans based on genetic mutations, biomarkers, and response probabilities. Seamlessly integrated into EHR workflows, gSage accelerates decision-making—turning breakthrough science into bedside action.
.jpg)